ArticleClinical case reports2025
Navigating Rare Presentations: Recurrent Burkitt Lymphoma Presenting as a Jejunal Mass.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Navigating Rare Presentations: Recurrent Burkitt Lymphoma Presenting as a Jejunal Mass.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Burkitt lymphoma (BL) is an aggressive B-cell malignancy characterized by rapid progression and MYC gene translocations. Jejunal involvement in BL is rare compared to more common sites like the lymph nodes and central nervous system. Diagnosing BL in the jejunum is particularly challenging as it can mimic other gastrointestinal conditions, necessitating a high index of suspicion and histopathological confirmation. We present the case of a 37-year-old male with a history of stage III non-seminomatous testicular carcinoma, BL, deep venous thrombosis, pulmonary embolism, and hypogammaglobulinemia, who presented with abdominal pain and nausea. Imaging revealed peritoneal carcinomatosis and a left hemiabdomen mass concerning malignancy. Given his medical history of previously diagnosed BL in the gastrohepatic ligament lymph node and imaging findings, BL relapse was suspected. Push enteroscopy with biopsy confirmed the recurrence of BL in the jejunum, with positive markers for CD45, CD20, BCL6, and c-Myc. Despite aggressive supportive care, the patient succumbed to his disease. This case highlights the importance of early recognition of BL, particularly in rare extra-nodal sites like the jejunum. Further research is needed to improve early detection and treatment outcomes for patients with relapsed or refractory BL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.